| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/25/2010 | US20100048551 Tricyclic Compounds Useful as Inhibitors of Kinases |
| 02/25/2010 | US20100048549 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
| 02/25/2010 | US20100048547 Pi 3-kinase inhibitors and methods of their use |
| 02/25/2010 | US20100048539 Compounds and compositions as protein kinase inhibitors |
| 02/25/2010 | US20100048536 Novel Substituted Diaryl Azepine Derivatives as Integrin Ligands |
| 02/25/2010 | US20100048529 New 2-Azetidinone Derivatives Useful In The Treatment Of Hyperlipidaemic Conditions |
| 02/25/2010 | US20100048515 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders |
| 02/25/2010 | US20100048495 Core 2 GlcNAc-T inhibitors III |
| 02/25/2010 | US20100048488 Immunomodulatory peptides |
| 02/25/2010 | US20100048481 Controlled Release Composition |
| 02/25/2010 | US20100048479 Adrenal grk2 activity as a therapeutic target for heart failure |
| 02/25/2010 | US20100048475 Method of Treating Dyspnea Associated with Acute Heart Failure |
| 02/25/2010 | US20100048470 Immunotoxins for the treatment of diseases related to cmv infection |
| 02/25/2010 | US20100048465 Peptide mimics of melanocyte stimulating hormone |
| 02/25/2010 | US20100048453 Oxazole and thiazole ppar modulator |
| 02/25/2010 | US20100047367 Compounds and methods for their use |
| 02/25/2010 | US20100047322 Combination antihypertensive wafer |
| 02/25/2010 | US20100047312 Use of bioactive and radiopaque material for stent coating |
| 02/25/2010 | US20100047236 Antibody variants |
| 02/25/2010 | US20100047218 Reversible immortalization |
| 02/25/2010 | US20100047215 Stem cell targeting methods |
| 02/25/2010 | US20100047211 Method of growth of mesenchymal cells under non-adherent conditions for clinical applications |
| 02/25/2010 | US20100047210 Systems and Methods for Positioning of Needles and Other Devices Within Body Tissue |
| 02/25/2010 | US20100047206 Powdery composition for nasal administration |
| 02/25/2010 | DE102008038222A1 Indazol-5-carbonsäurehydrazid-derivate Indazole-5-carboxylic acid derivatives |
| 02/25/2010 | CA2734804A1 Use of dabigatranetexilate for treating patients with pulmonary hypertension |
| 02/25/2010 | CA2734787A1 Substituted 5-aminopyrazoles and use thereof |
| 02/25/2010 | CA2733551A1 Arabinoxylans for modulating the barrier function of the intestinal surface |
| 02/24/2010 | EP2157097A1 Specific binding agents of human angiopoietin-2 |
| 02/24/2010 | EP2157093A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof |
| 02/24/2010 | EP2157092A1 Remedy for diabetes |
| 02/24/2010 | EP2157091A1 Inhibitors of phosphatidylinositol 3-kinase |
| 02/24/2010 | EP2157089A1 The therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 02/24/2010 | EP2157084A1 5-phenyl-3-pyridazinone derivative |
| 02/24/2010 | EP2157083A2 Pharmaceutical compositions containing crystalline form (I) of lercanidipine hydrochloride |
| 02/24/2010 | EP2157081A1 Indolinones substituted in six locations, their manufacture and their application as medicine |
| 02/24/2010 | EP2155748A1 Urotensin ii receptor antagonists |
| 02/24/2010 | EP2155732A1 Amorphous olmesartan medoxomil |
| 02/24/2010 | EP2155726A1 Phthalazinone derivatives and their use as medicament to treat cancer |
| 02/24/2010 | EP2155700A1 Beta-keto-amide derivatives useful as ion channel modulators |
| 02/24/2010 | EP2155697A1 Substituted piperazines |
| 02/24/2010 | EP2155334A2 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia |
| 02/24/2010 | EP2155198A2 Piperidine/piperazine derivatives |
| 02/24/2010 | EP2155184A2 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies |
| 02/24/2010 | EP2154998A2 Kit of nutritional compositions for infants with fat and carbohydrate content adapted to the particular stage of development |
| 02/24/2010 | EP2059520B1 1,4,5,6,7,8-hexahydro-i,2,5-triaza-azulene derivatives as orexin receptor antagonists |
| 02/24/2010 | EP2029596B1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 02/24/2010 | EP1689381B1 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases (smc proliferation) |
| 02/24/2010 | EP1605976B1 PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 02/24/2010 | EP0837696B1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 02/24/2010 | CN101653603A Peptides and antibodies binding to anionic phospholipids and aminophospholipids and their use in treating disease |
| 02/24/2010 | CN101653354A Noninvasive measurements of chemical substances |
| 02/24/2010 | CN100591689C Solid salts of benzazepine compounds and its uses in preparing pharmaceutical compound containing them |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one |
| 02/23/2010 | US7667053 Cannabinoid-1 (CB1) receptor antagonists and/or inverse agonists; e.g. N-(2,3-bis(4-chlorophenyl)-1-methylpropyl)-1,4-benzodioxane-2-carboxamide; psychological disorders, eating disorders |
| 02/23/2010 | US7667040 Azacyclic ethynyl derivatives |
| 02/23/2010 | US7667021 Neutralizing human anti-IGFR antibody |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667007 αvβ3-specific antibodies |
| 02/23/2010 | US7666983 peptides that activate the DNA binding activity of the wild-type form of the p53 tumor suppressor, as well as of certain tumor-derived p53 mutants |
| 02/23/2010 | US7666900 ATP-binding cassette transport 1 (ABCA1) stabilizers; using probucol spiroquinone/probucol diphenoquinone as prophylactic/therapeutic agents to decrease ABCA1 expression; low-HDL (high-density lipoprotein) cholesterolemia; arteriosclerosis; pharmacogenetics |
| 02/23/2010 | US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12 |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/23/2010 | US7666867 Heteroindanes: a new class of potent cannabimimetic ligands |
| 02/23/2010 | US7666848 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 02/23/2010 | US7666839 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 02/23/2010 | US7666832 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666647 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666408 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | CA2470492C Aqueous compositions containing metronidazole |
| 02/23/2010 | CA2468234C Acetyl l-carnitine fumarate and process for preparing the same |
| 02/23/2010 | CA2446890C Deuterated 3-piperidinopropiophenones and pharmaceutical drugs containing these compounds |
| 02/23/2010 | CA2433021C Isoindole-imide compounds, compositions, and uses thereof |
| 02/23/2010 | CA2374905C Pyrrolidinyl, piperidinyl or homopiperidinyl-substituted benzopyran derivatives for treating impaired fundic relaxation |
| 02/23/2010 | CA2335461C Calcium channel blockers |
| 02/23/2010 | CA2329930C Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 02/23/2010 | CA2154698C Therapeutic inhibitor of vascular smooth muscle cells |
| 02/18/2010 | WO2010019914A2 Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre |
| 02/18/2010 | WO2010019646A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
| 02/18/2010 | WO2010019540A1 Treatment of pulmonary arterial hypertension |
| 02/18/2010 | WO2010019417A2 Chymase inhibitors |
| 02/18/2010 | WO2010018867A1 Di-substituted benzopyrane compound |
| 02/18/2010 | WO2010018800A1 Acetyl pyrrolidinyl indole derivative |
| 02/18/2010 | WO2010018777A1 Odor-controlling method |
| 02/18/2010 | WO2010018764A1 Anti-angiogenic agent, and screening method and screening kit for same |
| 02/18/2010 | WO2010018652A1 Agent for promoting neuronal differentiation and method therefor |
| 02/18/2010 | WO2010017653A1 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof |
| 02/18/2010 | WO2010017632A1 Methods for stimulating chondrogenesis utilizing a potassium channel inhibitor |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2009129260A3 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| 02/18/2010 | WO2009127398A3 Conjugated linoleic acid derivatives |
| 02/18/2010 | WO2009111551A3 Hemorrhoid treatment device |
| 02/18/2010 | WO2008132712A3 Combination pharmaceutical compositions |
| 02/18/2010 | US20100041731 Solid states of atorvastatin potassium |